AstraZeneca reports 9% rise in Q3 2022 total revenue
For the rare disease sector, total revenue was $1.74bn, indicating a growth of 4%.
Filings
Merck reports 14% rise in worldwide sales in Q3 2022
BMS reports 3% decline in total revenues in Q3 2022
Johnson & Johnson reports 1.9% rise in Q3 2022 sales
Filings buzz in pharma: 56% increase in big data mentions since Q2 of 2021
Filings buzz in pharmaceuticals: 16% decrease in cloud computing mentions in Q2 of 2022
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
